Temporal alteration of serum G-CSF and VEGF levels in perinatal asphyxia treated with head cooling

Cytokine

Volumn 60, Issue 3, 2012, Pages 812-814

  Okazaki, Kaoru ^a   Kusaka, Takashi ^b   Kondo, Masatoshi ^c   Kozawa, Kunihisa ^d   Yoshizumi, Masakazu ^d   Kimura, Hirokazu ^e  

^a National Hospital Organization   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^d GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Asphyxia; G CSF; Neonate; Serum; VEGF

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN;

APGAR SCORE; ARTICLE; BIRTH; BRAIN PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INDUCED HYPOTHERMIA; MEDICAL DEVICE; NEWBORN; NEWBORN INTENSIVE CARE; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCALP COOLING;

ASPHYXIA NEONATORUM; BRAIN; COLD TEMPERATURE; CRYOTHERAPY; CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEAD; HUMANS; INFANT, NEWBORN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84868001455     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.001     Document Type: Article

References (19)

1. Shalak L., Perlman J.M. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 2004, 80:125-141.
2. Polderman K.H. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet 2008, 371:1955-1969.
3. Yenari M., Kitagawa K., Lyden P., Perez-Pinzon M. Metabolic downregulation: a key to successful neuroprotection?. Stroke 2008, 39:2910-2917.
4. Vexler Z.S., Tang X.N., Yenari M.A. Inflammation in adult and neonatal stroke. Clin Neurosci Res 2006, 6:293-313.
5. Okazaki K., Kondo M., Kato M., Kakinuma R., Nishida A., Noda M., et al. Elevation of high-mobility group box 1 concentration in asphyxiated neonates. Neonatology 2008, 94:105-109.
6. Battin M.R., Penrice J., Gunn T.R., Gunn A.J. Treatment of term infants with head cooling and mild systemic hypothermia (35.0°C and 34.5°C) after perinatal asphyxia. Pediatrics 2003, 111:244-251.
7. Kimura H., Kato M., Ikeda M., Nagai A., Okada Y., Naito S., et al. Sulfonated human immunoglobulin enhances CD16-linked CD11b expression on human neutrophils. Cell Biol Int 2003, 27:913-919.
8. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000, 106:829-838.
9. Shimotake J., Derugin N., Wendland M., Vexler Z.S., Ferriero D.M. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010, 41:343-349.
10. Solaroglu I., Tsubokawa T., Cahill J., Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965-974.
11. Solaroglu I., Cahill J., Jadhav V., Zhang J.H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006, 37:1123-1128.
12. Yata K., Matchett G.A., Tsubokawa T., Tang J., Kanamaru K., Zhang J.H. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res 2007, 1145:227-238.
13. Lassus P., Teramo K., Nupponen I., Markkanen H., Cederqvist K., Andersson S. Vascular endothelial growth factor and angiogenin levels during fetal development and in maternal diabetes. Biol Neonate 2003, 84:287-292.
14. Chirico G., Ciardelli L., Cecchi P., De Amici M., Gasparoni A., Rondini G. Serum concentration of granulocyte colony stimulating factor in term and preterm infants. Eur J Pediatr 1997, 156:269-271.
15. Gunn A.J., Gluckman P.D. Head cooling for neonatal encephalopathy: the state of the art. Clin Obstet Gynecol 2007, 50:636-651.
16. Sahni R., Sanocka U.M. Hypothermia for hypoxic-ischemic encephalopathy. Clin Perinatol 2008, 35:717-734.
17. Kuhn P., Messer J., Paupe A., Espagne S., Kacet N., Mouchnino G., et al. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr 2009, 155:324-330.
18. Miura E., Procianoy R.S., Bittar C., Miura C.S., Miura M.S., Mello C., et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2010, 107:30-35.
19. Kusaka S., Shima C., Wada K., Arahori H., Shimojyo H., Sato T., et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008, 92:1450-1455.